Global FISH Probe Market Size, Share, Price, Trends, Growth, Report and Forecast 2021-2026
The new report by Expert Market Research titled, ‘Global FISH Probe Market Size, Share, Price, Trends, Growth, Report and Forecast 2021-2026’, gives an in-depth analysis of the global FISH probe market, assessing the market based on its segments like technology, type, application, end-use, and major regions.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analyzing the market based on the SWOT and Porter’s Five Forces models.
Request a free sample copy in PDF or view the report [email protected] https://www.expertmarketresearch.com/reports/fish-probe-market/requestsample
The key highlights of the report include:
Market Overview (2016-2026)
- Historical Market Size (2020): USD 668.67 Million
- Forecast CAGR (2021-2026): 7.4%
- Forecast Market Size (2026): USD 1026.21 Million
The demand for in-vitro diagnostics (IVD) testing for the detection of numerous chronic illnesses is increasing, which in turn is driving the growth of the market. The high degree of dependability, speed, and sensitivity of the FISH probe method is linked to the growing need for IVD, which is pushing up the demand for the FISH probe market. Moreover, in medical diagnostics, DNA probe-based diagnostics is gaining popularity for determining suspected illnesses caused by pathogens or bacteria.
In addition, the identification of new sectors for diagnostic markets, greater automation of diagnostic procedures, and investments in pharmacogenomics and pharmaceutical research are all driving the industry forward. Over the forecast period, the rising frequency of genetic diseases including Acute Lymphoblastic Leukemia (ALL) is expected to fuel market expansion.
Explore the full report with the table of [email protected] https://www.expertmarketresearch.com/reports/fish-probe-market
Industry Definition and Major Segments
FISH (Fluorescent In Situ Hybridisation) is a molecular cytogenetic method that employs fluorescent probes that bind to just the portions of a nucleic acid sequence that have a high degree of sequence complementarity. The method was created in the 1980s by researchers to detect the presence of specific sequences of DNA on chromosomes.
The industry can be broken down based on technology into:
- Flow FISH
- Q FISH
- Other FISH
Based on type, the market is bifurcated into:
The RNA segment can be further divided into mRNA, miRNA, and other.
The industry can be categorized by application into:
- Cancer Research
- Genetic Diseases
The cancer research segment can be further classified into lung, breast, bladder, hematological, gastric, prostate, cervical, and other.
By end-use, the market is segregated into:
- Companion Diagnostics
Regionally, the industry can be segmented into:
- North America
- Asia Pacific
- Middle East and Africa
- Latin America
Recently, some key industrial developments have showcased the potential to drive the growth of the market over the forecast period. For example, BCL2 Breakapart, 57 BCL6 Breakapart, 58 CCND1 Breakapart, 58 IGH Breakapart, 59 IGH/BCL2 Translocation, Dual Fusion, and 60 IGH/CCND1 Translocation, Dual Fusion are some of the new products for multiple myeloma FISH probes, which have been introduced by CytoCell.
Key Market Players
The major players in the market are Oxford Gene Technology (OGT) Group, PerkinElmer Inc., Abnova Corporation, LGC Limited, Genemed Biotechnologies Inc., and Others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Anisha Luccas, Business Consultant
Email: [email protected]
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA